US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Live Cell Imaging Market by Product (Equipment, Consumables, Software), Technology (Fluorescence Recovery after Photobleaching, High-Content Screening) & by Application (Cell Biology, Stem Cells, Drug Discovery) - Analysis & Global Forecast to 2019
5/12/2015 | published by: MarketsandMarkets
... years, the live cell imaging market has witnessed various technological advancements in order to study the functions of live cells that meet the needs of academic and government institutes, pharmaceutical and biotechnology industries, contract research ...  |  read more...
USD 4,650
Skin And Skin Structure Infections (SSSI)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (SSSI). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Skin And Skin Structure Infections (SSSI) Report helps to identify emerging players with ...  |  read more...
USD 1,250
Skin And Skin Structure Infections (SSSI) Caused By Bacteria-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... the Skin And Skin Structure Infections (SSSI) Caused By Bacteria. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Skin And Skin Structure ...  |  read more...
USD 1,250
Skin And Skin Structure Infections by S.Pneumoniae-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Structure Infections by S.Pneumoniae. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Skin And Skin Structure Infections by S.Pneumoniae Report helps to ...  |  read more...
USD 1,250
Spasticity-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Spasticity Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Spasticity- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Spinal Stenosis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Spinal Stenosis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Spinal Stenosis- Pipeline ...  |  read more...
USD 1,250
Spondylitis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Spondylitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Spondylitis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Squamous Non-Small Cell Lung Cancer-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Squamous Non-Small Cell Lung Cancer Report helps to identify emerging players with potentially strong product information ...  |  read more...
USD 1,250
1,3-Beta-Glucan Synthase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 1,3-Beta-Glucan Synthase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Dehydrogenase Type 1 (11ßHSD1) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitors Report helps ...  |  read more...
USD 1,250
30S Ribosomal Subunit (30S RNA) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... RNA) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 30S Ribosomal Subunit (30S RNA) Inhibitors Report helps to identify emerging players ...  |  read more...
USD 1,250
4-1BB (CD137) Agonist -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 4-1BB (CD137) Agonist Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
50S Ribosomal Subunit (50S RNA) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... RNA) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 50S Ribosomal Subunit (50S RNA) Inhibitors Report helps to identify emerging players ...  |  read more...
USD 1,250
5-Alpha Reductase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-Alpha Reductase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
5-HT1 Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-HT1 Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, 5-HT1 Agonists- ...  |  read more...
USD 1,250
5-HT1 Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-HT1 Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, 5-HT1 Antagonists- ...  |  read more...
USD 1,250
5-HT1B Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-HT1B Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, 5-HT1B Antagonists- ...  |  read more...
USD 1,250
5-HT1F Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-HT1F Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, 5-HT1F Agonists- ...  |  read more...
USD 1,250
5-HT2 Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-HT2 Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, 5-HT2 Antagonists- ...  |  read more...
USD 1,250
5-HT2A Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-HT2A Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, 5-HT2A Agonists- ...  |  read more...
USD 1,250
5-HT2C Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-HT2C Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, 5-HT2C Agonists- ...  |  read more...
USD 1,250
5-HT2C Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-HT2C Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, 5-HT2C Antagonists- ...  |  read more...
USD 1,250
5-HT3 Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-HT3 Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, 5-HT3 Agonists- ...  |  read more...
USD 1,250
5-HT4 Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-HT4 Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, 5-HT4 Antagonists- ...  |  read more...
USD 1,250
5-HT4 Partial Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The 5-HT4 Partial Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
1    3    5  6  7  8  9  10